SJ-815 / SillaJen - LARVOL DELTA

Characterization of Oncolytic Vaccinia Virus Harboring the Human IFNB1 and CES2 Transgenes. (PubMed, Cancer Res Treat) - "SJ-815 demonstrates distinct characteristics gained from the inserted IFNB1 and CES2 transgenes. The potent antitumor effects of SJ-815, particularly when combined with irinotecan, against multiple solid tumors make SJ-815 an attractive candidate for further preclinical and clinical studies."

Journal • Oncolytic Virus • Gastrointestinal Cancer • Hepatology • Melanoma • Oncology • Pancreatic Cancer • Solid Tumor